Certara Announces Transition Plan for Chief Financial Officer

Rhea-AI Summary

Certara, Inc. (Nasdaq: CERT) announced that John Gallagher will replace Andrew Schemick as Chief Financial Officer effective April 1, 2023. Gallagher brings nearly 25 years of experience, including his recent role as CFO of Cue Health and various positions at Becton Dickinson. Schemick transitions to Senior Vice President of Corporate Operations, focusing on operational excellence during Certara's growth. CEO William Feehery expressed excitement about Gallagher’s expertise to drive growth and thanked Schemick for his leadership over the past nine years, which included an IPO and significant capitalizations.

Positive

• John Gallagher's appointment as CFO is expected to enhance financial strategy and growth.
• Gallagher brings extensive experience from Cue Health and Becton Dickinson.
• Schemick’s new role focuses on operational excellence, indicating a strong management team.

Negative

• None.

PRINCETON, N.J., March 01, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), announced today that John Gallagher will succeed Andrew Schemick as Chief Financial Officer, effective April 1, 2023.  Mr. Schemick will transition into a newly created position as Senior Vice President, Corporate Operations and Integration, and he will be focused on supporting John’s transition, and then building operational excellence as Certara continues to grow. 

John brings almost 25 years of experience to Certara, most recently serving as the Chief Financial Officer of Cue Health, a publicly traded healthcare technology company. Prior to Cue, John worked for Becton Dickinson (BD) for 9 years, where he served in multiple roles, including CFO of its Medical Segment, Chief Accounting Officer, Corporate Treasurer, and FP&A Leader.  John also brings related experience from General Electric and Ford, where he began his career.

William Feehery, President and Chief Executive Officer, stated, “I am excited to welcome John to the Certara team as we continue executing our business strategy and creating strong value for all stakeholders. John brings extensive financial expertise that we will leverage to drive growth across our business.”

Feehery continued, “I want to thank Andy for his outstanding leadership and financial stewardship as Certara’s CFO over the past nine years, during which time we consummated an initial public offering and multiple equity capitalizations from blue-chip investors. Our partnership has been a great privilege, and I look forward to continuing our work together as Andy takes on a new and critical role focusing on operational synergies and value-enhancing integration work.”

About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Daniel Yunger
Kekst CNC
daniel.yunger@kekstcnc.com

FAQ

Who is the new CFO of Certara?

John Gallagher will become the new Chief Financial Officer of Certara effective April 1, 2023.

What is Andrew Schemick's new position at Certara?

Andrew Schemick will become Senior Vice President of Corporate Operations at Certara.

What experience does John Gallagher have?

John Gallagher has nearly 25 years of experience, including roles as CFO at Cue Health and various positions at Becton Dickinson.

What did Certara's CEO say about John Gallagher?

CEO William Feehery expressed excitement about Gallagher’s financial expertise to drive growth across the business.